AbbVie : ABBV

All AbbVie Articles

613 Articles

William Temple | Dec 13, 2025 at 12:26 PM EST

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Building wealth through dividends requires more than chasing high yields. The path to “getting rich” combines meaningful current income with…

William Temple | Dec 12, 2025 at 7:22 AM EST

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

Dividend investing rewards patience. The best dividend stocks don’t just pay consistently—they raise payouts year after year, compounding income for…

Rich Duprey | Dec 10, 2025 at 12:19 PM EST

This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence

Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, policy uncertainties…

Michael Williams | Dec 10, 2025 at 10:13 AM EST

At A 8% Yield, Global X SuperDividend SDIV) Is One Of The Most Impressive High Income ETFs Today

The Global X SuperDividend ETF (NYSEARCA:SDIV) generates its 8% yield by investing in 100 of the highest dividend-yielding equities across…

Lee Jackson | Dec 10, 2025 at 8:09 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More

Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap…

Michael Williams | Dec 9, 2025 at 5:53 PM EST

Schwab’s SCHD ETF Is Mostly Solid, But 1 Top Holding Is Concerning

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) is a popular income choice for retirees. The fund generates income by holding…

David Beren | Nov 19, 2025 at 12:23 PM EST

2 Dividend Stocks to Hold Through Any Market Cycle

Trying to build a portfolio that can survive recessions, inflation, and market volatility is one of the biggest challenges any…

Lee Jackson | Nov 13, 2025 at 8:10 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More

Pre-Market Stock Futures: The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials,…

Lee Jackson | Nov 4, 2025 at 8:11 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite…

Lee Jackson | Oct 17, 2025 at 7:12 AM EDT

5 Safe Forever Dividend Stocks To Buy Now and Hold For Life

At 24/7 Wall St., we have closely followed dividend-paying stocks for over 15 years. With a growing audience of savvy…

Rich Duprey | Oct 14, 2025 at 9:29 AM EDT

I have invested in dividends for 11 years—These income machines pay me every quarter without a hitch

Over the past 11 years, I’ve built a portfolio centered on steady dividend payers, stocks that deliver reliable income quarter…

John Seetoo | Oct 4, 2025 at 10:01 AM EDT

Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)

Geopolitical events, judicial rulings, new law legislation, and policy changes are all circumstances occurring on domestic and international stages that…

Rich Duprey | Oct 1, 2025 at 10:47 AM EDT

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last…

Omor Ibne Ehsan | Sep 28, 2025 at 12:11 PM EDT

Build Your Lifetime Income Stream: 5 Dividend ETFs Worth Owning

If you are looking for a source of income that outlives you, look into dividend ETFs that are time-tested over…

Rich Duprey | Sep 24, 2025 at 11:14 AM EDT

Unlock Endless Income: SCHD’s Latest Dividend Hike Makes It a Must-Buy ETF

Why Dividend Growth Investing Builds Lasting Wealth In the world of investing, few strategies match the quiet power of dividend…

1 … 4 5 6 7 8 … 41

AbbVie : ABBV

All AbbVie Articles

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence

At A 8% Yield, Global X SuperDividend SDIV) Is One Of The Most Impressive High Income ETFs Today

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More

Schwab’s SCHD ETF Is Mostly Solid, But 1 Top Holding Is Concerning

2 Dividend Stocks to Hold Through Any Market Cycle

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

5 Safe Forever Dividend Stocks To Buy Now and Hold For Life

I have invested in dividends for 11 years—These income machines pay me every quarter without a hitch

Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Build Your Lifetime Income Stream: 5 Dividend ETFs Worth Owning

Unlock Endless Income: SCHD’s Latest Dividend Hike Makes It a Must-Buy ETF

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

AbbVie : ABBV

All AbbVie Articles

5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine

Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks

This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence

At A 8% Yield, Global X SuperDividend SDIV) Is One Of The Most Impressive High Income ETFs Today

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More

Schwab’s SCHD ETF Is Mostly Solid, But 1 Top Holding Is Concerning

2 Dividend Stocks to Hold Through Any Market Cycle

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

5 Safe Forever Dividend Stocks To Buy Now and Hold For Life

I have invested in dividends for 11 years—These income machines pay me every quarter without a hitch

Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Build Your Lifetime Income Stream: 5 Dividend ETFs Worth Owning

Unlock Endless Income: SCHD’s Latest Dividend Hike Makes It a Must-Buy ETF

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line